Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

1993 Press Releases
DateTitleCompany
27 Jul 15 EMD Millipore Adds Protein Pegylation to Portfolio of Services for Biopharmaceutical Industry through Collaboration with celares GmbH EMD Millipore,
Published by
PharmiWeb.com
27 Jul 15 Catabasis Pharmaceuticals and UT Southwestern Medical Center Enter into a Sponsored Research Agreement for CAT-2000 Series in Serious Lipid Disorders Catabasis Pharmaceuticals,
Published by
PharmiWeb.com
27 Jul 15 Aeterna Zentaris Commences Promotional Activities for EMD Serono's Saizen® [Somatropin (rDNA origin) for Injection] Aeterna Zentaris,
Published by
PharmiWeb.com
27 Jul 15 Invion and Hovione Sign Joint Development and Licensing Agreement for Inhaled Zafirlukast BG Medicine,
Published by
PharmiWeb.com
27 Jul 15 BG Medicine Welcomes U.S. Market Introduction of Automated Galectin-3 Test at the 2015 American Association for Clinical Chemistry Annual Meeting BG Medicine,
Published by
PharmiWeb.com
27 Jul 15 Materialise NV Signs 5 Year Partnership Agreement with Japan Medical Dynamic Marketing, Inc. Materialise NV,
Published by
PharmiWeb.com
27 Jul 15 RedHill Biopharma Provides Update on RHB-106 Program Partnered with Salix Pharmaceuticals RedHill Biopharma,
Published by
PharmiWeb.com
27 Jul 15 RedHill Biopharma to Host Second Quarter 2015 Financial Results Conference Call on July 29, 2015 RedHill Biopharma,
Published by
PharmiWeb.com
27 Jul 15 RedHill Biopharma Announces Closing of Public Offering of Its American Depository Shares RedHill Biopharma,
Published by
PharmiWeb.com
27 Jul 15 Edgemont Capital Partners Completes Sale of SCYNEXIS Contract Research and Development Business to Avista Pharma Solutions, an Ampersand Capital Partners Portfolio Company Edgemont Capital,
Published by
PharmiWeb.com
27 Jul 15 Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders Mylan,
Published by
PharmiWeb.com
27 Jul 15 TxCell Receives Fast Track Designation From FDA For Ovasave TxCell,
Published by
PharmiWeb.com
27 Jul 15 Stem Cell Delivery Method Shows Promise for Treating End Stage Heart Failure University of Utah,
Published by
PharmiWeb.com
27 Jul 15 Gelesis Expands Ongoing Weight Loss Study to Serve as U.S. Pivotal Trial, Significantly Accelerating Development Timeline Gelesis,
Published by
PharmiWeb.com
27 Jul 15 New Study Demonstrates LINX® Safety and Efficacy Rivals Laparoscopic Nissen Fundoplication Torax Medical,
Published by
PharmiWeb.com
27 Jul 15 Yissum Introduces a Novel Technology for Drug Screening and Testing of Orphan Diseases without Utilizing Animal Models Yissum,
Published by
PharmiWeb.com
27 Jul 15 New Data Show Pluristem's PLX Cells Regulate the Immune System Pluristem Therapeutics,
Published by
PharmiWeb.com
27 Jul 15 Inovio Pharmaceuticals Initiates Clinical Trial of INO-5150 DNA Immunotherapy for Prostate Cancer Inovio Pharmaceuticals,
Published by
PharmiWeb.com
27 Jul 15 Novo Nordisk and NBA Legend Dominique Wilkins Launch My Diabetes Dream Team Sweepstakes Novo Nordisk,
Published by
PharmiWeb.com
27 Jul 15 Mylan Comments on Teva's Agreement to Acquire Allergan's Generic Drug Unit Mylan,
Published by
PharmiWeb.com
27 Jul 15 Mylan Acknowledges Exercise of Full Call Option by the Independent Foundation Mylan,
Published by
PharmiWeb.com
27 Jul 15 European Medicines Agency Validates and Grants Accelerated Assessment of Marketing Authorization Application for Empliciti (elotuzumab) For the Treatment of Multiple Myeloma in Patients Who Have Received One or More Prior Therapies Bristol-Myers Squibb,
Published by
PharmiWeb.com
27 Jul 15 Acura Pharmaceuticals to Host Second Quarter 2015 Financial Results Conference Call on August 4, 2015 Acura Pharmaceuticals,
Published by
PharmiWeb.com
27 Jul 15 Allergan Accelerates Transformation to Branded Growth Pharma Leader by Divesting Global Generics Business to Teva for $40.5 Billion Allergan,
Published by
PharmiWeb.com
27 Jul 15 Alnylam Initiates Phase 1/2 Clinical Trial for ALN-AAT, an Investigational RNAi Therapeutic for the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease (Alpha-1 Liver Disease) Alnylam,
Published by
PharmiWeb.com
27 Jul 15 Aratana Therapeutics Announces Positive Pilot Field Study of AT-002 in Cats Aratana Therapeutics,
Published by
PharmiWeb.com
27 Jul 15 Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares Anthera Pharmaceuticals,
Published by
PharmiWeb.com
27 Jul 15 Cardiome Submits Supplemental New Drug Submission (SNDS) For Aggrastat To Health Canada Cardiome,
Published by
PharmiWeb.com
27 Jul 15 Chiasma, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares Chiasma,
Published by
PharmiWeb.com
27 Jul 15 Novartis Foundation confirms new members of its Board of trustees, including new Chairman Dr. Joerg Reinhardt Novartis,
Published by
PharmiWeb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.